LRRK2 and Parkinson disease: Whether these effects are related to the specific mode of action of type I kinase inhibitors is unknown, but, together these data reinforce the importance of developing LRRK2-specific type II kinase inhibitors both as potential therapeutics against PD and as chemical probes to explore the functional significance of LRRK2’s different conformational states in cells and in vivo.